INUS
Straddle Chart

Markets / Mutual funds / Index Funds (equity)

Mutual fundsSIF

ICICI Prudential Nifty Pharma Index Fund - Regular Plan - Growth

NAVs of 8 Nov 2026

ICICI Prudential Mutual Fund · Index & ETFs fund · Regular plan · Growth

Index Funds (equity)Regular · Growth
NAV · 6 Nov 2026
₹21.0962 ▲ 1.20%
ICICI Prudential Mutual Fund
Fund size₹151 crJuly - September 2026
1-month range₹19.13 – 21.10
1 year+24.89%rank 4 of 376
Expense ratio1.13%regular plan, a year
5 years–a year

What the fund does

The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.

BenchmarkNifty Pharma TRI
Launched14 Dec 2022
Fund houseICICI Prudential Mutual Fund

NAV history

192021 2026-08-122026-08-252026-09-072026-09-212026-10-052026-10-162026-10-30

Returns

1 week
+2.99%avg 5.2%
1 month
+5.60%avg 4.6%
3 months
+5.02%avg -1.3%
6 months
+15.65%avg 1.5%
This year
+22.47%avg 0.3%
1 year
+24.89%avg 1.4% · #4/376
3 years (a year)
+22.67%avg 10.6% · #3/187

Bars: this plan; the thin mark is the Index Funds (equity) average (regular plans, growth option). Over a year: yearly averages (CAGR). Past returns do not guarantee future returns. Information only, not investment advice.

Monthly returns (%)

YearJanFebMarAprMayJunJulAugSepOctNovDec
2024+3.4
2025-6.9-7.4+6.6+1.6-0.3+2.3+3.6-3.9-1.4+3.0+3.6-1.3
2026-4.5+5.8-3.3+4.6+4.5+4.0+4.9+2.4-2.8+2.5+3.0

Each month's change in NAV (the current month to the latest NAV).

What if you had invested?

Worked out from this plan's actual NAVs. SIP: invested on the first NAV of each month. Taxes and exit loads are not included. Past returns do not guarantee future returns. Information only, not investment advice.

Portfolio as on 30 Sept 2026

Stocks held2022 lines in all
Top 10 stocks78.2%of the fund
Short positions-1.4%sold through derivatives
Net equity98.5%long stocks and derivatives minus shorts

Where the money is

Equity 99.9%Cash & others 0.1%Short -1.4%

Sectors (stocks held)

Pharmaceuticals & Biotechnology
99.9%

Changes since 31 Aug 2026

Share of fund30 Sept 202631 Aug 2026Change
Stocks held99.9%99.9%+0.01
Short positions-1.4%-1.0%-0.43
Cash & others0.1%0.1%-0.01
Top 10 stocks78.2%78.8%-0.68
Number of stocks20200
Bought more 2
  • Dr. Reddy's Laboratories Ltd.+0.67
  • Laurus Labs Ltd.+0.46
Cut back 3
  • Sun Pharmaceutical Industries Ltd.-1.26
  • Biocon Ltd.-0.29
  • Lupin Ltd.-0.25

Change is in percentage points. Bought more and cut back list stocks whose share of the fund moved by at least 0.25 points. A share can also move because the price changed, not only because the fund traded.

Stocks held 20

HoldingSector / type% of fund
Sun Pharmaceutical Industries Ltd.
INE044A01036		Pharmaceuticals & Biotechnology19.50%
Divi's Laboratories Ltd.
INE361B01024		Pharmaceuticals & Biotechnology11.97%
Laurus Labs Ltd.
INE947Q01028		Pharmaceuticals & Biotechnology7.82%
Cipla Ltd.
INE059A01026		Pharmaceuticals & Biotechnology7.68%
Dr. Reddy's Laboratories Ltd.
INE089A01031		Pharmaceuticals & Biotechnology7.62%
Torrent Pharmaceuticals Ltd.
INE685A01028		Pharmaceuticals & Biotechnology7.16%
Lupin Ltd.
INE326A01037		Pharmaceuticals & Biotechnology5.00%
Aurobindo Pharma Ltd.
INE406A01037		Pharmaceuticals & Biotechnology4.68%
Glenmark Pharmaceuticals Ltd.
INE935A01035		Pharmaceuticals & Biotechnology3.56%
Alkem Laboratories Ltd.
INE540L01014		Pharmaceuticals & Biotechnology3.16%
Zydus Lifesciences Ltd.
INE010B01027		Pharmaceuticals & Biotechnology2.92%
Mankind Pharma Ltd.
INE634S01028		Pharmaceuticals & Biotechnology2.88%
IPCA Laboratories Ltd.
INE571A01038		Pharmaceuticals & Biotechnology2.71%
Biocon Ltd.
INE376G01013		Pharmaceuticals & Biotechnology2.62%
Gland Pharma Ltd.
INE068V01023		Pharmaceuticals & Biotechnology2.34%
Sai Life Sciences Ltd.
INE570L01029		Pharmaceuticals & Biotechnology2.14%
Wockhardt Ltd.
INE049B01025		Pharmaceuticals & Biotechnology1.77%
Ajanta Pharma Ltd.
INE031B01049		Pharmaceuticals & Biotechnology1.67%
Abbott India Ltd.
INE358A01014		Pharmaceuticals & Biotechnology1.43%
Piramal Pharma Ltd.
INE0DK501011		Pharmaceuticals & Biotechnology1.30%

Short positions 1

HoldingSector / type% of fund
Net Current Assets–-1.44%

Debt, money market and cash 1

HoldingSector / type% of fund
TREPS–1.50%

From the fund house's monthly portfolio (icicipruamc.com), as on 30 Sept 2026. Percentages are of the fund's net assets; short positions are negative. Published about ten days after each month ends.

Risk

Volatility14.1%yearly, from daily NAVs
Worst fall-16.05%11 Oct 2024 → 28 Feb 2025

Volatility: how much the NAV moves, as a yearly figure (higher = bumpier). Worst fall: the biggest drop from a high, in the NAV history we hold (from 30 Dec 2022).

Fund details

Fund size (average AUM, July - September 2026)₹151 cr across all plans · this plan ₹45.52 cr
Fund houseICICI Prudential Mutual Fund
CategoryIndex & ETFs · Index Funds (equity)
PlanRegular
OptionGrowth
Expense ratio (TER)Direct 0.51% · Regular 1.13% (5 Nov 2026)
Minimum investment₹1,000 · additional ₹1,000
Scheme code (AMFI)150929
ISININF109KC18L6
NAV date6 Nov 2026

Scheme details from the fund's scheme summary document filed with AMFI; expense ratios from AMFI's daily filings.

Other plans of this fund

PlanNAV1 year
Direct · Growth₹21.6272+25.71%
Direct · IDCW₹21.6282+25.71%
Regular · IDCW₹21.0962+24.89%

Top Index Funds (equity) funds (regular plans)

Fund1 year3 years (a year)
ICICI Prudential NASDAQ 100 Index Fund+10.81%+25.41%
Motilal Oswal S&P 500 Index Fund+15.40%+23.79%
ICICI Prudential Nifty Pharma Index Fund+24.89%+22.67%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund+21.72%+21.26%
ICICI Prudential Nifty Auto Index Fund+5.20%+20.60%
Motilal Oswal BSE Enhanced Value Index Fund-0.92%+20.10%
UTI Nifty 500 Value 50 Index Fund+3.94%+19.96%
Motilal Oswal BSE Enhanced Value Index Fund-1.57%+19.29%

All Index Funds (equity) funds ranked › · Compare with others ›

← All mutual funds

Information only, not investment advice.

What is the NAV of ICICI Prudential Nifty Pharma Index Fund - Regular Plan - Growth today?

₹21.0962 as of 6 Nov 2026, from AMFI's official NAV data.

What are the returns of ICICI Prudential Nifty Pharma Index Fund - Regular Plan - Growth?

1 year: 24.89%, 3 years: 22.67% a year

How does ICICI Prudential Nifty Pharma Index Fund rank in its category?

4 of 376 Index Funds (equity) funds (regular plans, growth option) by 1-year return.

What is the difference between direct and regular plans?

Both invest in the same portfolio. Direct plans are bought straight from the fund house and pay no distributor commission, so their expenses are lower and their NAV grows slightly faster.